Stocktoria

Advanced Biomed Inc. ADVB

Nasdaq · stock · Services-Medical Laboratories · website · IPO 2025-03-06

Advanced Biomed Inc. statistics & valuation

P / B2.1×

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20242025
Operating margin (%)
20242025
Return on equity (%)
-167.30% -93.70% 20242025
Shares outstanding
20.0M 20.5M 20242025
Net debt ($)
20242025
Share buybacks ($)
20242025
Return on assets (%)
-62.40% -23.80% 20242025
Free cash flow margin (%)
20242025
Debt / equity (×)
20242025
EPS ($)
-$0.14 -$0.16 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Return on assets-23.8%-62.4%
Return on equity-93.7%-167.3%
Current ratio1.311.12

Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.